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The point mutation S120G in human nucleoside diphosphate kinase A, identiﬁed in patients with
neuroblastoma, causes a protein folding defect. The urea-unfolded protein cannot refold in vitro,
and accumulates as a molten globule folding intermediate. We show here that the trimethyla-
mine-N-oxide (TMAO) corrects the folding defect and stimulated subunit association. TMAO also
substantially increased the stability to denaturation by urea of both wild-type and S120G mutant.
A non-native folding intermediate accumulated in the presence of 4.5–7 M urea and of 2 M TMAO.
It was inactive, monomeric, contained some secondary structure but no tertiary structure and dis-
played a remarkable stability to denaturation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
NDPKs play a major role in the synthesis of non-adenine nucle-
oside (and deoxynucleoside) triphosphates [1]. In addition, mam-
malian NDPKs have been shown to have regulatory functions, as
in cancer progression (reviewed in [2]). The S120G mutation of
the human nucleoside diphosphate kinase A (product of the
nm23-H1 gene) (NDPK-HA) has been identiﬁed in patients with
high-grade neuroblastomas [3]. Although the mutant protein has
enzymatic activity [4,5], its regulatory effects are abnormal [6–8].
We showed that the mutation caused a protein folding defect.
While the wild-type enzyme refolded and formed active hexamers,
S120G-NDPK-HA could not be renatured in vitro, but accumulated
as a molten globule folding intermediate2 (MG) having measurablechemical Societies. Published by E
osphate kinase A (product of
nt of the human NDPK-HA;
acid; K-pn, killer-of-prune;
er constant; MG, the molten
G*, the folding intermediate
nd 2 M TMAO
cu).
mie, Department of Cellular
ed, Germany.
ates are better described as an
ue to their ﬂexible nature. We
nding.secondary structure but no tertiary structure [5]. The crystal struc-
tures of the wild-type and S120G mutant of NDPK-HA in complex
with ADP are identical within the experimental error, rms = 0.29 Å
[9]. The cellular effects of the mutated protein are therefore dues
to the persistence of a partially folded form of the protein in the cell.
There are several other examples in the literature of proteins in-
volved in the control of cancer progression or of their mutants which
are misfolded in vitro and possible in vivo [10,11]. The study of the
correction of the folding defect by a chemical chaperone is therefore
of general biological and pharmaceutical interest [12,13]. We report
here the rescue of the S120G mutant structure and enzymatic activ-
ity by the natural osmolyte trimethylamine-N-oxide (TMAO). The
folding intermediates were often evoked in the recent literature as
being essential during formation of amyloid ﬁbrils [14,15]. We dis-
covered that S120G mutant of the human NDPK-HA (S120G-NDPK-
HA) assembles to amyloid ﬁbrils by moderate heating [24]. Under-
standing the effect TMAO, on stability by MG is of great interest in
this new and exciting perspective.2. Materials and methods
The expression, puriﬁcation, storage and enzymatic activity of
wild-type NDPK-HA and its S120G mutant were reported previ-
ously [5,16]. TMAO (Sigma–Aldrich) was freed from ﬂuorescent
contaminants by treatment with 10 g active charcoal per liter of
4 M TMAO solution. CD spectra were recorded with a Jasco J-810lsevier B.V. All rights reserved.
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Fig. 1. Effect of 2 M trimethylamine-N-oxide (TMAO) on the reactivation rate of
human nucleoside diphosphate kinase A (product of the nm23-H1 gene) (NDPK-
F. Georgescauld et al. / FEBS Letters 583 (2009) 820–824 821spectropolarimeter. Because both urea and TMAO strongly absorb
light in the far-UV range, some measurements were performed in
a 10-lm cuvette. This allowed the recording of good quality spec-
tra up to 190 nm. Fluorescence was measured using a LS50B spec-
troﬂuorimeter (Perkin–Elmer). Fluorescence quenching by
acrylamide was studied using standard methods, with data correc-
tion for dilution. The plots of I0/I versus the acrylamide concentra-
tions were linear for the native and MG states, while a modiﬁed
Stern–Volmer plot which takes into consideration the static
quenching [17] ﬁtted better the data for the folding intermediate
which accumulated in the presence of 4.5–7 M urea and 2 M TMAO
(MG*) and for the unfolded protein. Protein denaturation by urea
was analyzed as described [5]. Brieﬂy, native or urea-unfolded pro-
tein was diluted in 0–8 M urea solutions to a ﬁnal concentration of
1 lM; and incubated for 16 h at 25 C. The following parameters
were measured: residual/acquired enzymatic activity, intrinsic
protein ﬂuorescence intensity (excitation at 295 nm, emission at
340 nm) and ﬂuorescence intensity of 4,40-dianilino-1,10-binaph-
thyl-5,50-disulfonic acid (BisANS) added at 1 lM (excitation at
390 nm, emission at 480 nm). Size-exclusion chromatography
was performed on a Superdex 75 column equilibrated with buffer
A containing 150 mM NaCl. In some experiments BisANS was
mixed continuously with the efﬂuent and its ﬂuorescence was
measured using a ﬂow-through cuvette.
All measurements were performed at 25 C in buffer A (100 mM
Tris–HCl (pH 8.0) containing 1 mM DTT), unless otherwise
indicated.HA) (A) and S120G mutant of the human NDPK-HA (S120G-NDPK-HA) (B). The
enzyme reactivation was followed in the absence of additives (full circles), and in
the presence of 2 M TMAO (empty circles), of 1 mM ATP (empty squares) and in the
presence of 1 mM ATP and 2 M TMAO (full squares). The Mg2+ concentration was
5 mM. Native hexameric enzyme was used as the control.
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Fig. 2. Size-exclusion chromatography analysis of the reactivated S120G mutant.
The urea-unfolded enzyme was diluted into buffer (empty circles) or in the
presence of 2 M trimethylamine-N-oxide (TMAO) (full circles), at the ﬁnal concen-
tration of 10 lg/ml. Two hundred microliters were injected into the column. (A) The
protein was followed by its intrinsic ﬂuorescence. (B) In a separate experiment the
column efﬂuent was mixed with BisANS at the ﬁnal concentration of 1 lM and its
ﬂuorescence monitored at 480 nm (excitation at 370 nm). No symbols, the native
enzyme; dashed line, myoglobin.3. Results and discussion
3.1. Reactivation of NDPK-HA and S120G-NDPK-HA in the presence of
TMAO
NDPK-HA is fully catalytically active in its hexameric form only.
The correctly-folded native protein is almost inactive in its mono-
meric form [18,19]. ‘‘Reactivation” therefore reﬂects both correct
folding and assembly of the hexamer. Fig. 1 shows the reactivation
kinetics of wild-type and S120G mutant NDPK-HA, diluted in buf-
fer after denaturation by 8 M urea. Addition of 2 M TMAO was not
required for the reactivation of wild-type NDPK-HA but it did con-
siderably increase its reactivation rate. In contrast, the S120G mu-
tant could not be reactivated without addition of TMAO.
Stimulation of S120G-NDPK-HA reactivation was very signiﬁcant.
TMAO therefore assisted subunit folding and association. The effect
was largest at 2.0 M while higher concentrations of TMAO were
inhibitory (not shown). In the presence of MgATP, where the en-
zyme becomes phosphorylated [16], reactivation of NDPK-HA
and S120G-NDPK-HA was faster (Fig. 1). Since phosphorylation
promoted correct folding, it results that TMAO stimulated subunits
assembly.
Analysis by size exclusion chromatography of the S120G-NDPK-
HA renatured in buffer demonstrated that it has a size larger than
the native subunits (Fig. 2A) and bound BisANS (Fig. 2B) which is
typical for the MG state. Native subunits had a size similar to myo-
globin used as a marker. In the presence of TMAO, most of the pro-
tein was hexameric. Some aggregated material eluted in the void
volume, which bound BisANS, suggesting partially folded aggre-
gated species.
3.2. TMAO stabilized the NDPK-HA to denaturation by urea
To gain more information about the effect of TMAO on NDPK-
HA and on S120G-NDPK-HA folding and assembly, the denatur-
ation by urea and subsequent renaturation of NDPK-HA and
S120G-NDPK-HA has been studied in the presence and in the ab-sence of the osmolyte. A quantitative thermodynamic analysis of
the denaturation and renaturation of hexameric NDPKs can not
be made since the reaction was not reversible, in the sense that
denaturation and renaturation pathways were not identical [20].
Fig. 3 illustrates the effect of TMAO on the unfolding by urea
and on the subsequent refolding of NDPK-HA and S120G-NDPK-
HA, followed by the intrinsic protein ﬂuorescence (Fig. 3A and B)
and by activity measurements (Fig. 3C and D). The persistence of
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Fig. 3. Effect of 2 M trimethylamine-N-oxide (TMAO) on the urea-induced unfolding and refolding of human nucleoside diphosphate kinase A (product of the nm23-H1 gene)
(NDPK-HA) (A, C, E) and S120G mutant of the human NDPK-HA (S120G-NDPK-HA) (B, D, F). The followed parameters were the intrinsic protein ﬂuorescence intensity (panels
A and B), residual/acquired enzymatic activity (C, D) and the ﬂuorescence of BisANS added to the ﬁnal concentration of 1 lM (E, F). Circles indicate experiments in the absence
TMAO while squares indicate the presence of 2 M TMAO. Full symbols, denaturation and empty symbols, renaturation. The lines do not have any theoretical meaning and are
shown for clarity only.
822 F. Georgescauld et al. / FEBS Letters 583 (2009) 820–824the MG intermediate was monitored by the binding of BisANS
(Fig. 3E and F).
The denaturation and the inactivation curve were coincident
with the NDPK-HA. An intermediate appeared in the transition re-
gion, as detected by BisANS binding (Fig. 3E). In the presence of
2 M TMAO the active hexamer was considerably stabilized
(Fig. 3A). An inactive species accumulated in solutions of 4.5–
7.5 M urea in the presence of 2 M TMAO, which we called MG*
(see next section). It unfolds at >8 M urea or 3.6 M GuHCl (not
shown). Similar to NDPK-HA, the active S120G-NDPK-HA hexamer
was stabilized by 2 M TMAO. The half-inactivation urea concentra-
tion increased from 2.5 to 3.5 M in the presence of 2 M TMAO
(Fig. 3D). The renaturation pattern changed dramatically. The rena-
turation curve was non-cooperative in the absence of TMAO, as re-
ported before [5] (Fig. 3B). The non-cooperative renaturation curve
is characteristic of some, but not of all, MG folding intermediate
states. In the presence of TMAO, the renaturation curve becomes
cooperative. This demonstrated that the renatured mutant enzyme
was native in the presence of TMAO. The native monomers could
associate to active hexamers. Indeed, reactivation level of the
S120G-NDPK-HA was almost 100% in the presence of 2 M TMAO
while it was less than 5% in its absence (Fig. 3D). As with the
wild-type enzyme, an inactive species MG* accumulated in the
presence of 2 M TMAO plus >4.5 M urea. The intensity ﬂuorescence
plateau was lower than that with the wild-type protein. A tentative
explanation on the lower ﬂuorescence intensity would be that MG*
was less structured species, as compared to the wild-type protein.The substitution of a serine with a glycine destabilizes the MG* by
stabilizing the unfolded state via the increase of its entropy [21].
The size-exclusion chromatographic analysis agrees with this
hypothesis (see the next section). BisANS ﬂuorescence reﬂecting
binding to MG* was much lower in the presence of TMAO
(Fig. 3F). The MG* unfolds at >8 M urea.
3.3. A non-native intermediate accumulated in the presence of urea
and 2 M TMAO
The denaturation curves for wild-type and S120G mutant pro-
teins, in solutions of 4.5–7 M urea with 2 M TMAO, revealed the
presence of an inactive species displaying the characteristics of a
folding intermediate, MG*. This intermediate detected for both
wild-type and S120 mutant proteins, possesses a secondary struc-
ture as demonstrated by the far-UV CD spectrum (Fig. 4A). How-
ever, the absence of a CD signal in the near-UV range (Fig. 4B)
demonstrates that the intermediate lacks tertiary structure. Simi-
lar CD spectra were obtained for S120G mutant and wild-type
NDPK-HA.
The folding intermediate MG* had ﬂuorescence properties dif-
ferent from the molten globule intermediate MG. When excited
at 295 nm, the maximum emission ﬂuorescence for MG* was at
347 nm; whereas for MG it was 339.5 nm. The maximum emission
ﬂuorescence values for the native and unfolded proteins were at
339 and 352 nm, respectively. The enhancement of ﬂuorescence
of BisANS upon binding MG* which was lower than that with its
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Fig. 4. Characterization of the folding intermediate which accumulated in the
presence of 4.5–7 M urea and 2 M TMAO (MG*) folding intermediate by far-UV (A)
and near-UV (B) circular dichroism spectra of the S120G mutant of the human
NDPK-HA (S120G-NDPK-HA). The protein was analyzed without additives (full
circles) or in the presence of 7 M urea (empty diamonds) or 7 M urea plus 2 M
trimethylamine-N-oxide (TMAO) (full diamonds). The protein concentration was
118 lM. The optical path lengths were 10 lm (A) and 1 cm (B).
0
100
200
300
400
500
600
9 10 11 12 13 14 15In
tr
in
si
c 
pr
ot
ei
n 
flu
or
es
ce
nc
e 
(a
. u
.)
Elution volume (mL)
A
0
100
200
300
400
500
600
700
800
9 10 11 12 13 14 15In
tr
in
si
c 
pr
ot
ei
n 
flu
or
es
ce
nc
e 
(a
. u
.)
Elution volume(mL)
B
Fig. 5. Size-exclusion chromatographic analysis of the folding intermediate MG*.
The human nucleoside diphosphate kinase A (product of the nm23-H1 gene)
(NDPK-HA) (A) and S120G mutant of the human NDPK-HA (S120G-NDPK-HA) (B),
native (full symbols) or unfolded in 9 M urea (empty symbols), were injected into a
Superdex 75 column equilibrated with buffer A containing 0.2 M NaCl (circles) or
buffer A containing 0.2 M NaCl plus 6 M urea and 2 M trimethylamine-N-oxide
(TMAO) (squares). The elution proﬁle of myoglobin (of same size as the NDKA
subunit) is shown in panel A without symbols. The protein was detected by
ﬂuorescence (excitation at 280 nm, emission at 340 nm).
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Fig. 6. Quenching of the intrinsic protein ﬂuorescence by acrylamide, of the S120G
mutant of the human NDPK-HA (S120G-NDPK-HA). Excitation was at 295 nm.
Empty squares, native protein; full circles, protein in 2 M trimethylamine-N-oxide
(TMAO) and 6 M urea; full squares; protein refolded in buffer A; triangles, protein
unfolded in 6 M urea. The lines correspond to the best ﬁt described in the text.
F. Georgescauld et al. / FEBS Letters 583 (2009) 820–824 823binding MG. Furthermore, the BisANS emission spectrum was
maximal at 510 nm when bound to MG* but at 485 nm when
bound to MG.
The Stokes radius of the folding intermediate MG* in the pres-
ence of 2 M TMAO and 6 M urea was similar to that of MG, but
was peaks broader with the S120G mutant (Fig. 5) suggesting that
it is heterogeneous.
Finally, we used acrylamide quenching experiments to measure
tryptophan accessibility (Fig. 6). The plots of I0/I versus acrylamide
concentrations were linear. In the presence of 6 M urea and 2 M
TMAO, the Stern–Volmer constant of the intermediate species
MG* (Ksv 6.9 M1) was higher than in the native protein (Ksv
4.5 M1) but much lower than that of the unfolded protein in
7 M urea (Ksv 11.1 M1). The Ksv for MG was 5.9 M1. Therefore,
MG* is less compact than the native protein, but more compact
than in the unfolded protein.
4. Conclusion
TMAO corrects the folding defects of several mutated proteins
of medical importance: mutant branched-chain a-ketoacid decar-
boxylase [10]; a1-anti-trypsin [11,22]; defective aquaporin-2 traf-
ﬁcking in nephrogenic diabetes insipidus [11]; and partial
restoration of defective chloride conductance in DeltaF508 CF mice
[23]. Here we showed that TMAO corrects the folding defect of the
S120G mutant protein. It has been suggested TMAO stabilizes the
native state because its unfavorable interaction with the peptide
bonds of the main chain of the protein in the unfolded state.
The urea-unfolded S120G-NDPK-HA may refold and associate
into active hexamers in the presence of 2 M TMAO but not in its ab-sence. TMAO has a dual effect: it stabilizes the native subunits with
respect to molten globule state, and promotes their association to
the hexamer. In addition, the osmolyte stabilizes the S120G-NDPK-
HA and NDPK-HA towards denaturation by urea. This was not the
result of a simpliﬁcation of the folding pathway by the disappear-
ance of the folding intermediate MG. Rather, a monomeric folding
intermediate MG* accumulated in the presence of 2 M TMAO and
4.5–7 M urea which has an extraordinary stability to denaturation
by urea. Similar stabilization of folding intermediates have previ-
ously been reported [22,23]. The tendency of the S120G-NDPK-
HA to populate non-native folding intermediates is probably essen-
tial for its assembly in amyloid ﬁbrils [24].
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